Accuray (Nasdaq: ARAY) reported earnings on May 7. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q3), Accuray missed estimates on revenues and missed expectations on earnings per share.

Compared to the prior-year quarter, revenue shrank significantly. Non-GAAP loss per share grew. GAAP loss per share grew.

Margins contracted across the board.

Revenue details
 Accuray chalked up revenue of $70.5 million. The six analysts polled by S&P Capital IQ expected a top line of $76.8 million on the same basis. GAAP reported sales were 31% lower than the prior-year quarter's $101.8 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at -$0.37. The seven earnings estimates compiled by S&P Capital IQ averaged -$0.22 per share. Non-GAAP EPS were -$0.37 for Q3 compared to -$0.13 per share for the prior-year quarter. GAAP EPS were -$0.42 for Q3 versus -$0.21 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 28.4%, 710 basis points worse than the prior-year quarter. Operating margin was -35.5%, much worse than the prior-year quarter. Net margin was -44.2%, much worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $88.9 million. On the bottom line, the average EPS estimate is -$0.26.

Next year's average estimate for revenue is $324.4 million. The average EPS estimate is -$0.91.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 509 members out of 536 rating the stock outperform, and 27 members rating it underperform. Among 127 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 122 give Accuray a green thumbs-up, and five give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Accuray is outperform, with an average price target of $7.33.

Is Accuray the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.